You are here

Article info

Article menu
Download PDFPDF
Letter
Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key

Authors

  1. Correspondence to Dr Alfons A den Broeder, Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands; a.denbroeder{at}maartenskliniek.nl
View Full Text

Citation

den Broeder N, Bouman CAM, Kievit W, et al
Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key
Annals of the Rheumatic Diseases 2019;78:141-142.

Publication history

  • Received April 9, 2018
  • Revised June 28, 2018
  • Accepted August 1, 2018
  • First published August 27, 2018.
Online issue publication 
May 10, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.